US Patent Issued to STAIDSON (BEIJING) BIOPHARMACEUTICALS on Oct. 21 for "Antibodies specifically recognizing Pseudomonas PcrV and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,434, issued on Oct. 21, was assigned to STAIDSON (BEIJING) BIOPHARMACEUTICALS Co. LTD. (Beijing).

"Antibodies specifically recognizing Pseudomonas PcrV and uses thereof" was invented by Maorong Yu (Beijing), Zhong Li (Beijing) and Chao Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies including antigen-binding fragment thereof that specifically recognizing Pseudomonas PcrV. Also provided are methods of making and using these antibodies."

The patent was filed on July 7, 2020, under Application No. 17/625,724.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...